Complete regression of local cancer using temperature-sensitive liposomes combined with ultrasound-mediated hyperthermia

Journal of Controlled Release

Volumn 172, Issue 1, 2013, Pages 266-273

  Kheirolomoom, Azadeh ^a   Lai, Chun Yen ^a   Tam, Sarah M ^a   Mahakian, Lisa M ^a   Ingham, Elizabeth S ^a   Watson, Katherine D ^a   Ferrara, Katherine W ^a  

^a University of California   (United States)

Author keywords

Doxorubicin; Extended survival; Hyperthermia; Temperature sensitive liposomes; Toxicity

Indexed keywords

BREAST CANCER MODELS; CARDIAC HYPERTROPHY; DOXORUBICIN; EXTENDED SURVIVAL; HYPERTHERMIA; SYSTEMIC TOXICITIES; TEMPERATURE SENSITIVE; TEMPERATURE-SENSITIVE LIPOSOMES;

BIOCHEMISTRY; CHEMOTHERAPY; COPPER; DISEASES; LIPOSOMES; TOXICITY; ULTRASONICS;

TUMORS;

DOXORUBICIN; GLUCONATE COPPER; LIPOSOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER INHIBITION; CANCER REGRESSION; CANCER SURVIVAL; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; DRUG STABILITY; HYPERTHERMIC THERAPY; IN VITRO STUDY; MOUSE; NONHUMAN; PH; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT OUTCOME; ULTRASOUND; ULTRASOUND SCANNER;

DOXORUBICIN; EXTENDED SURVIVAL; HYPERTHERMIA; TEMPERATURE-SENSITIVE LIPOSOMES; TOXICITY;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BREAST; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; COPPER; DOXORUBICIN; FEMALE; HYDROGEN-ION CONCENTRATION; HYPERTHERMIA, INDUCED; LIPOSOMES; MICE; TEMPERATURE; ULTRASONICS;

EID: 84884327479     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2013.08.019     Document Type: Article

References (44)

1. G. Kong, R.D. Braun, and M.W. Dewhirst Hyperthermia enables tumor-specific nanoparticle delivery: effect of particle size Cancer Res. 60 2000 4440 4445
2. G.A. Koning, A.M.M. Eggermont, L.H. Lindner, and T.L.M. ten Hagen Hyperthermia and thermosensitive liposomes for improved delivery of chemotherapeutic drugs to solid tumors Pharm. Res. 27 2010 1750 1754
3. D. Needham, G. Anyarambhatla, G. Kong, and M.W. Dewhirst A new temperature-sensitive liposome for use with mild hyperthermia: characterization and testing in a human tumor xenograft model Cancer Res. 60 2000 1197 1201
4. P.S. Yarmolenko, Y.L. Zhao, C. Landon, I. Spasojevic, F. Yuan, D. Needham, B.L. Viglianti, and M.W. Dewhirst Comparative effects of thermosensitive doxorubicin-containing liposomes and hyperthermia in human and murine tumours Int. J. Hyperth. 26 2010 485 498
5. J. Fang, H. Nakamura, and H. Maeda The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect Adv. Drug Deliv. Rev. 63 2011 136 151
6. H. Maeda The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting G. Weber, Advances in Enzyme Regulation vol. 41 2001 Pergamon-Elsevier Science Ltd. Oxford 189 207
7. H. Maeda, H. Nakamura, and J. Fang The EPR effect for macromolecular drug delivery to solid tumors: improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo Adv. Drug Deliv. Rev. 65 2013 71 79
8. A.M. Ponce, B.L. Viglianti, D.H. Yu, P.S. Yarmolenko, C.R. Michelich, J. Woo, M.B. Bally, and M.W. Dewhirst Magnetic resonance imaging of temperature-sensitive liposome release: drug dose painting and antitumor effects J. Natl. Cancer Inst. 99 2007 53 63
9. B.L. Viglianti, A.M. Ponce, C.R. Michelich, D.H. Yu, S.A. Abraham, L. Sanders, P.S. Yarmolenko, T. Schroeder, J.R. MacFall, D.P. Barboriak, O.M. Colvin, M.B. Bally, and M.W. Dewhirst Chemodosimetry of in vivo tumor liposomal drug concentration using MRI Magn. Reson. Med. 56 2006 1011 1018
10. T.D. Tailor, G. Hanna, P.S. Yarmolenko, M.R. Dreher, A.S. Betof, A.B. Nixon, I. Spasojevic, and M.W. Dewhirst Effect of pazopanib on tumor microenvironment and liposome delivery Mol. Cancer Ther. 9 2010 1798 1808
11. T. Karino, S. Koga, and M. Maeta Experimental studies of the effects of local hyperthermia on blood flow, oxygen pressure and pH in tumors Jpn. J. Surg. 18 1988 276 283
12. T. Kusumoto, Y. Maehara, H. Baba, I. Takahashi, H. Kusumoto, S. Ohno, and K. Sugimachi Sequence dependence of the hyperthermic potential of carboplatin-induced cytotoxicity and intracellular platinum accumulation in Hela cells Br. J. Cancer 68 1993 259 263
13. A.A. Manzoor, L.H. Lindner, C.D. Landon, J.Y. Park, A.J. Simnick, M.R. Dreher, S. Das, G. Hanna, W. Park, A. Chilkoti, G.A. Koning, T.L.M. ten Hagen, D. Needham, and M.W. Dewhirst Overcoming limitations in nanoparticle drug delivery: triggered, intravascular release to improve drug penetration into tumors Cancer Res. 72 2012 5566 5575
14. R.D. Issels Hyperthermia adds to chemotherapy Eur. J. Cancer 44 2008 2546 2554
15. M. Urano, M. Kuroda, and Y. Nishimura For the clinical application of thermochemotherapy given at mild temperatures Int. J. Hyperth. 15 1999 79 107
16. T. Tagami, M.J. Ernsting, and S.D. Li Efficient tumor regression by a single and low dose treatment with a novel and enhanced formulation of thermosensitive liposomal doxorubicin J. Control. Release 152 2011 303 309
17. T. Tagami, J.P. May, M.J. Ernsting, and S.D. Li A thermosensitive liposome prepared with a Cu2 + gradient demonstrates improved pharmacokinetics, drug delivery and antitumor efficacy J. Control. Release 161 2012 142 149
18. Celsion Phase 3 study of ThermoDox with radiofrequency ablation (RFA) in treatment of hepatocellular carcinoma (HCC) [Internet] 2000 National Library of Medicine (US) Bethesda (MD) ([cited 2012 June 15]. Available from: http://www.clinicaltrials.gov/ct2/show/NCT00617981 NLM Identifier: NCT00617981)
19. Celsion Phase 1/2 study of ThermoDox with approved hyperthermia in treatment of breast cancer recurrence at the chest wall (DIGNITY) [Internet] 2000 National Library of Medicine (US) Bethesda (MD) ([cited 2012 June 15]. Available from: http://www.clinicaltrials.gov/ct2/show/NCT00826085 NLM Identifier: NCT0826085)
20. M. de Smet, E. Heijman, S. Langereis, N.M. Hijnen, and H. Grull Magnetic resonance imaging of high intensity focused ultrasound mediated drug delivery from temperature-sensitive liposomes: an in vivo proof-of-concept study J. Control. Release 150 2011 102 110
21. W.T. Al-Jamal, Z.S. Al-Ahmady, and K. Kostarelos Pharmacokinetics & tissue distribution of temperature-sensitive liposomal doxorubicin in tumor-bearing mice triggered with mild hyperthermia Biomaterials 33 2012 4608 4617
22. R.T.P. Poon, and N. Borys Lyso-thermosensitive liposomal doxorubicin: a novel approach to enhance efficacy of thermal ablation of liver cancer Expert. Opin. Pharmacother. 10 2009 333 343
23. C. Landon, J.Y. Park, D. Needham, and M.W. Dewhirst Nanoscale drug delivery and hyperthermia: the materials design and preclinical and clinical testing of low temperature-sensitive liposomes used in combination with mild hyperthermia in the treatment of local cancer Open Nanomed. J. 3 2011 38 64
24. A. Kheirolomoom, L.M. Mahakian, C.Y. Lai, H.A. Lindfors, J.W. Seo, E.E. Paoli, K.D. Watson, E.M. Haynam, E.S. Ingham, L. Xing, R.H. Cheng, A.D. Borowsky, R.D. Cardiff, and K.W. Ferrara Copper-doxorubicin as a nanoparticle cargo retains efficacy with minimal toxicity Mol. Pharm. 7 2010 1948 1958
25. M. Feng, Y.L. Yang, P.G. He, and Y.Z. Fang Spectroscopic studies of copper(II) and iron(II) complexes of adriamycin Spectrochim. Acta A Mol. Biomol. Spectrosc. 56 2000 581 587
26. S. Clerc, and Y. Barenholz Loading of amphipathic weak acids into liposomes in response to transmembrane calcium acetate gradients Biochim. Biophys. Acta Biomembr. 1240 1995 257 265
27. G. Haran, R. Cohen, L.K. Bar, and Y. Barenholz Transmembrane ammonium-sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases Biochim. Biophys. Acta 1151 1993 201 215
28. T.D. Madden, P.R. Harrigan, L.C.L. Tai, M.B. Bally, L.D. Mayer, T.E. Redelmeier, H.C. Loughrey, C.P.S. Tilcock, L.W. Reinish, and P.R. Cullis The accumulation of drugs within large unilamellar vesicles exhibiting a proton gradient - a survey Chem. Phys. Lipids 53 1990 37 46
29. L.D. Mayer, M.B. Bally, M.J. Hope, and P.R. Cullis Uptake of antineoplastic agents into large unilamellar vesicles in response to a membrane-potential Biochim. Biophys. Acta 816 1985 294 302
30. D.D. Lasic, B. Ceh, M.C.A. Stuart, L. Guo, P.M. Frederik, and Y. Barenholz Transmembrane gradient driven phase-transitions within vesicles - lessons for drug-delivery Biochim. Biophys. Acta Biomembr. 1239 1995 145 156
31. X.G. Li, D.J. Hirsh, D. Cabral-Lilly, A. Zirkel, S.M. Gruner, A.S. Janoff, and W.R. Perkins Doxorubicin physical state in solution and inside liposomes loaded via a pH gradient Biochim. Biophys. Acta Biomembr. 1415 1998 23 40
32. E.M. Bolotin, R. Cohen, L.K. Bar, N. Emanuel, S. Ninio, D.D. Lasic, and Y. Barenholz Ammonium sulfate gradients for efficient and stable remote loading of amphipathic weak bases into liposomes and ligandoliposomes J. Liposome Res. 4 1994 455 479
33. K.B. Wallace Nonenzymatic oxygen activation and stimulation of lipid-peroxidation by doxorubicin copper Toxicol. Appl. Pharmacol. 86 1986 69 79
34. L. Gianni, E.H. Herman, S.E. Lipshultz, G. Minotti, N. Sarvazyan, and D.B. Sawyer Anthracycline cardiotoxicity: from bench to bedside J. Clin. Oncol. 26 2008 3777 3784
35. S. Dromi, V. Frenkel, A. Luk, B. Traughber, M. Angstadt, M. Bur, J. Poff, J.W. Xie, S.K. Libutti, K.C.P. Li, and B.J. Wood Pulsed-high intensity focused ultrasound and low temperature sensitive liposomes for enhanced targeted drug delivery and antitumor effect Clin. Cancer Res. 13 2007 2722 2727
36. X.P. Ma, H.X. Pan, and J.L. Yi Combination sonodynamic therapy with immunoadjuvant may be a promising new modality for cancer treatment Med. Hypotheses 72 2009 418 420
37. P.M. Siegel, E.D. Ryan, R.D. Cardiff, and W.J. Muller Elevated expression of activated forms of Neu/ErbB-2 and ErbB-3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer EMBO J. 18 1999 2149 2164
38. J.K. Miller, D.L. Shattuck, E.Q. Ingalla, L.L. Yen, A.D. Borowsky, L.J.T. Young, R.D. Cardiff, K.L. Carraway, and C. Sweeney Suppression of the negative regulator LRIG1 contributes to ErbB2 overexpression in breast cancer Cancer Res. 68 2008 8286 8294
39. A. Kheirolomoom, D.E. Kruse, S. Qin, K.E. Watson, C.-Y. Lai, L.J.T. Young, R.D. Cardiff, and K.W. Ferrara Enhanced in vivo bioluminescence imaging using liposomal luciferin delivery system J. Control. Release 141 2010 128 136
40. J.K. Mills, and D. Needham The materials engineering of temperature-sensitive liposomes Methods Enzymol. 387 2004 82 113
41. A. Sindrilaru, T. Peters, S. Wieschalka, C. Baican, A. Baican, H. Peter, A. Hainzl, S. Schatz, Y. Qi, A. Schlecht, J.M. Weiss, M. Wlaschek, C. Sunderkotter, and K. Scharffetter-Kochanek An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice J. Clin. Invest. 121 2011 985 997
42. P.S. Yarmolenko, E.J. Moon, C. Landon, A. Manzoor, D.W. Hochman, B.L. Viglianti, and M.W. Dewhirst Thresholds for thermal damage to normal tissues: an update Int. J. Hyperth. 27 2011 320 343
43. D.N. Waterhouse, P.G. Tardi, L.D. Mayer, and M.B. Bally A comparison of liposomal formulations of doxorubicin with drug administered in free form: changing toxicity profiles Drug Saf. 24 2001 903 920
44. S.P. Qin, J.W. Seo, H. Zhang, J. Qi, F.R.E. Curry, and K.W. Ferrara An imaging-driven model for liposomal stability and circulation Mol. Pharm. 7 2010 12 21